Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigatorSite activation comes several months ahead of schedule, significantly accelerating Starton’s clinical program timelinePARAMUS, N.J. (BUSINESS WIRE) Starton Therapeutics Inc. (“Starton” or “the Company”.